Biotech firm Rubius Therapeutics gains state incentives, will open new plant

PROVIDENCE – R.I. Commerce Corp., the state’s economic development agency, on Thursday approved a package of tax reductions and incentives potentially worth more than $9 million for Rubius Therapeutics Inc. to open a pharmaceutical manufacturing plant in Smithfield. In return, the Cambridge, Mass.-based biotechnology company has pledged to create 160 jobs at the site with…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.